BD Achieves Milestone in AGILITY Study of Revello™ Vascular Covered Stent for Treatment of Peripheral Artery Disease

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...
Endovascular Today

BD Completes Enrollment of Iliac Cohort in AGILITY IDE Study of Revello Covered Stent

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...
MassDevice

BD completes enrollment in vascular covered stent study

BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.
TipRanks on MSN

Becton gets full enrollment in iliac artery patient cohort in AGILITY study

Becton Dickinson (BDX) announced full enrollment of the iliac artery patient cohort in its AGILITY investigational device ...
MedPage Today on MSN

RDN's Coverage Decision; Intracoronary Stem Cell Tx; Crab-Walk Technique for M-TEER

CMS issued a final National Coverage Determination (NCD) that green-lights renal denervation (RDN) for uncontrolled ...